"Phosphatonins" and the regulation of phosphorus homeostasis (Q36308619)

13 August 2017

1 reference

title

"Phosphatonins" and the regulation of phosphorus homeostasis (English)

1 reference

13 August 2017

Theresa J Berndt

1

1 reference

13 August 2017

Susan Schiavi

series ordinal

2

1 reference

13 August 2017

Rajiv Kumar

series ordinal

3

1 reference

13 August 2017

publication date

1 December 2005

1 reference

American Journal of Physiology - Renal Physiology

13 August 2017

published in

1 reference

13 August 2017

volume

289

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

F1170-82

1 reference

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

FGF23 is processed by proprotein convertases but not by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Renal Na/Pi-cotransporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The renal type II Na+/phosphate cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The Mobilization of Bone Mineral by 1,25-Dihydroxyvitamin D3in Hypophosphatemic Rats1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Parathyroid function and the renal excretion of 3'5'-adenylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The structure and regulation of protein phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Localization of NaPi-1, a Na-Pi cotransporter, in rabbit kidney proximal tubules. I. mRNA localization by reverse transcription/polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The Kidney as an Endocrine Organ for the Production of 1,25-Dihydroxyvitamin D3, a Calcium-Mobilizing Hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Dietary Phosphate Deprivation in Women and Men: Effects on Mineral and Acid Balances, Parathyroid Hormone and the Metabolism of 25-OH-Vitamin D*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

X-Linked hypophosphatemic rickets: a disease often unknown to affected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Control of 25-hydroxycholecalciferol metabolism by parathyroid glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Inhibition of MEPE cleavage by Phex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Protein tyrosine kinase structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

21 January 2018

Protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

A dibasic motif involved in parathyroid hormone-induced down-regulation of the type IIa NaPi cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Phosphorylation-Dephosphorylation of Enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Tumor-induced osteomalacia and the regulation of phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Studies on the topology of the renal type II NaPi-cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, gyro (Gy) mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Molecular mechanisms of renal apical Na/phosphate cotransport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Molecular aspects in the regulation of renal inorganic phosphate reabsorption: the type IIa sodium/inorganic phosphate co-transporter as the key player.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Molecular mechanisms in the regulation of renal proximal tubular Na/phosphate cotransport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Abnormal parathyroid function in the X-linked hypophosphatemic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The phosphatonin pathway: new insights in phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Phosphatonins: a new class of phosphate-regulating proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The control of phosphate excretion in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Control of phosphate excretion in uremic man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Role of 1,25-Dihydroxyvitamin D 3 in Maintaining Serum Phosphorus and Curing Rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Biological activity of 1,25-dihydroxyvitamin D3 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Cloning and expression of cDNA for a Na/Pi cotransport system of kidney cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00072.2005

10.1152/AJPRENAL.00072.2005

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference